Phase II Study of Combination of Lenalidomide / dose metronomic cyclophosphamide / prednisone for the treatment of patients over 75 years with newly diagnosed multiple myeloma [Estudio Fase II de Combinacion de Lenalidomida/Ciclofosfamida a dosis metronomicas/Prednisona para el tratamiento de pacientes mayores de 75 anos con mieloma multiple de nuevo diagnostico].

Trial Profile

Phase II Study of Combination of Lenalidomide / dose metronomic cyclophosphamide / prednisone for the treatment of patients over 75 years with newly diagnosed multiple myeloma [Estudio Fase II de Combinacion de Lenalidomida/Ciclofosfamida a dosis metronomicas/Prednisona para el tratamiento de pacientes mayores de 75 anos con mieloma multiple de nuevo diagnostico].

Completed
Phase of Trial: Phase II

Latest Information Update: 15 Jun 2014

At a glance

  • Drugs Lenalidomide (Primary) ; Cyclophosphamide; Prednisone
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top